The Comprehensive Sickle Cell Center (CSCC) at the Children's Hospital of Philadelphia is in its 14th year of operations. Our major goal has been to seek new information about the disease while translating acquired knowledge to the full benefit of the patient. In this regard, our CSCC has been organized from its inception with the care of the patients as its central focus around which research is organized. For the first time in the history of research in this genetic disease, a drug, hydroxyurea, has been licensed specifically for preventive management. Today, an increasing number of adult SCD patients lead lives of less pain and hospitalization because of their use of hydroxyurea. Bone marrow transplantation has succeeded in providing hematologic cure for 80% of those receiving sibling-matched donor transplant but this therapy is available for less than 15% of those who deserve a trial of it. Non-myeloablative transplant protocols now in early development promise to decrease post-transplant morbidity and increase the acceptability of stem cell transplantation to clinicians and patients/families. Transfusion therapy remains one of the most important therapeutic maneuvers in the management of SCD. Well-managed chronic transfusion therapy is able to keep an increasing number of patients from the occurrence or recurrence of major complications such as stroke, acute chest syndrome, and debilitating pain. In summary, progress has been made however, until we can assure the parents of a newborn with SCD that we can provide therapy that will prevent all the major and common complications of the disease, our work is far from being completed. This Center is excited about the opportunity to participate in the inter-Center collaborative clinical research studies, a new feature of the Comprehensive Centers for which we propose a prophylactic transfusion study. We have proposed a balanced program of exciting and innovative basic science research, a very promising translational project, and clinical and psychosocial studies that may lead soon to improved well-being of children and adolescents with sickle cell disease. We plan to continue our commitment to extend benefits of research to less developed areas of the sickle cell world.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-F (S1))
Program Officer
Evans, Gregory
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Children's Hospital of Philadelphia
United States
Zip Code
Wrotniak, Brian H; Schall, Joan I; Brault, Megan E et al. (2014) Health-related quality of life in children with sickle cell disease using the child health questionnaire. J Pediatr Health Care 28:14-22
Dougherty, Kelly A; Schall, Joan I; Kawchak, Deborah A et al. (2012) No improvement in suboptimal vitamin A status with a randomized, double-blind, placebo-controlled trial of vitamin A supplementation in children with sickle cell disease. Am J Clin Nutr 96:932-40
Dougherty, Kelly A; Schall, Joan I; Rovner, Alisha J et al. (2011) Attenuated maximal muscle strength and peak power in children with sickle cell disease. J Pediatr Hematol Oncol 33:93-7
Abdulmalik, Osheiza; Safo, Martin K; Seeholzer, Steven H et al. (2010) Hb Baden: structural and functional characterization. Am J Hematol 85:848-52
Enninful-Eghan, Henrietta; Moore, ReneƩ H; Ichord, Rebecca et al. (2010) Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease. J Pediatr 157:479-84
Schwartz, Lisa A; Radcliffe, Jerilynn; Barakat, Lamia P (2009) Associates of school absenteeism in adolescents with sickle cell disease. Pediatr Blood Cancer 52:92-6
Peranteau, William H; Heaton, Todd E; Gu, Yu-Chen et al. (2009) Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model. Biol Blood Marrow Transplant 15:293-305
Adachi, Kazuhiko; Ding, Min; Asakura, Toshio et al. (2009) Relationship between beta4 hydrogen bond and beta6 hydrophobic interactions during aggregate, fiber or crystal formation in oversaturated solutions of hemoglobin A and S. Arch Biochem Biophys 481:137-44
Rovner, Alisha J; Stallings, Virginia A; Kawchak, Deborah A et al. (2008) High risk of vitamin D deficiency in children with sickle cell disease. J Am Diet Assoc 108:1512-6
Adachi, Kazuhiko; Ding, Min; Surrey, Saul (2008) Role of the beta4Thr-beta73Asp hydrogen bond in HbS polymer and domain formation from multinucleate-containing clusters. Biochemistry 47:5441-9

Showing the most recent 10 out of 23 publications